228 related articles for article (PubMed ID: 37620502)
1. Development of a three-dimensional organoid model to explore early retinal phenotypes associated with Alzheimer's disease.
Lavekar SS; Harkin J; Hernandez M; Gomes C; Patil S; Huang KC; Puntambekar SS; Lamb BT; Meyer JS
Sci Rep; 2023 Aug; 13(1):13827. PubMed ID: 37620502
[TBL] [Abstract][Full Text] [Related]
2. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
Yin J; VanDongen AM
ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
[TBL] [Abstract][Full Text] [Related]
4. Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology.
James E; Vielle A; Cusato K; Li H; Lee B; Parween S; Howell A; Johnson NR; Chial HJ; Potter H; Vergara MN
Front Cell Neurosci; 2024; 18():1340448. PubMed ID: 38323188
[TBL] [Abstract][Full Text] [Related]
5. Simple modeling of familial Alzheimer's disease using human pluripotent stem cell-derived cerebral organoid technology.
Choe MS; Yeo HC; Kim JS; Lee J; Lee HJ; Kim HR; Baek KM; Jung NY; Choi M; Lee MY
Stem Cell Res Ther; 2024 Apr; 15(1):118. PubMed ID: 38659053
[TBL] [Abstract][Full Text] [Related]
6. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
7. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
Pavoni S; Jarray R; Nassor F; Guyot AC; Cottin S; Rontard J; Mikol J; Mabondzo A; Deslys JP; Yates F
PLoS One; 2018; 13(12):e0209150. PubMed ID: 30557391
[TBL] [Abstract][Full Text] [Related]
9. Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals.
Schultz N; Byman E; ; Wennström M
J Alzheimers Dis; 2020; 73(3):1201-1209. PubMed ID: 31884473
[TBL] [Abstract][Full Text] [Related]
10. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
[TBL] [Abstract][Full Text] [Related]
11. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease like neuropathology in Down syndrome cortical organoids.
Zhao HH; Haddad GG
Front Cell Neurosci; 2022; 16():1050432. PubMed ID: 36568886
[No Abstract] [Full Text] [Related]
13. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye.
Lee S; Jiang K; McIlmoyle B; To E; Xu QA; Hirsch-Reinshagen V; Mackenzie IR; Hsiung GR; Eadie BD; Sarunic MV; Beg MF; Cui JZ; Matsubara JA
Front Neurosci; 2020; 14():758. PubMed ID: 32848548
[TBL] [Abstract][Full Text] [Related]
15. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
16. The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration.
Yan Y; Bejoy J; Marzano M; Li Y
Cells; 2019 Mar; 8(3):. PubMed ID: 30875781
[TBL] [Abstract][Full Text] [Related]
17. Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells.
Yan Y; Song L; Bejoy J; Zhao J; Kanekiyo T; Bu G; Zhou Y; Li Y
Tissue Eng Part A; 2018 Jul; 24(13-14):1125-1137. PubMed ID: 29361890
[TBL] [Abstract][Full Text] [Related]
18. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
19. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
Zhao J; Fu Y; Yamazaki Y; Ren Y; Davis MD; Liu CC; Lu W; Wang X; Chen K; Cherukuri Y; Jia L; Martens YA; Job L; Shue F; Nguyen TT; Younkin SG; Graff-Radford NR; Wszolek ZK; Brafman DA; Asmann YW; Ertekin-Taner N; Kanekiyo T; Bu G
Nat Commun; 2020 Nov; 11(1):5540. PubMed ID: 33139712
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
